Cargando…
Editorial: New GPCR targets and modulators to treat CNS disorders
Autores principales: | De Deurwaerdère, Philippe, Ponimaskin, Evgeni, Chagraoui, Abdeslam, Di Giovanni, Giuseppe |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9763925/ https://www.ncbi.nlm.nih.gov/pubmed/36561894 http://dx.doi.org/10.3389/fnmol.2022.1104336 |
Ejemplares similares
-
Editorial: Contemporary Perspective on 5-HT(2C) Receptor Function and Its Pharmacological Targeting
por: De Deurwaerdère, Philippe, et al.
Publicado: (2020) -
Neurobiological and Pharmacological Perspectives of D3 Receptors in Parkinson’s Disease
por: Chagraoui, Abdeslam, et al.
Publicado: (2022) -
Cannabinoid 1/2 Receptor Activation Induces Strain-Dependent Behavioral and Neurochemical Changes in Genetic Absence Epilepsy Rats From Strasbourg and Non-epileptic Control Rats
por: De Deurwaerdère, Philippe, et al.
Publicado: (2022) -
Dopamine D3 Receptor: Contemporary Views of Its Function and Pharmacology for Neuropsychiatric Diseases
por: De Deurwaerdère, Philippe, et al.
Publicado: (2021) -
Lorcaserin Alters Serotonin and Noradrenaline Tissue Content and Their Interaction With Dopamine in the Rat Brain
por: Di Giovanni, Giuseppe, et al.
Publicado: (2020)